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Intracellular calcium transients are necessary for
platelet-derived growth factor but not extracellular
matrix protein–induced vascular smooth muscle
cell migration
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Purpose: Vascular smooth muscle cell (SMC) migration is a critical component of the hyperplastic response that leads to
recurrent stenosis after interventions to treat arterial occlusive disease. We investigated the relationship between
intracellular calcium ([Ca2]i) and migration of vascular SMCs in response to platelet-derived growth factor (PDGF) and
extracellular matrix (ECM) proteins.
Methods: Human saphenous vein SMCs were used for all experiments. SMC migration in response to agonists was
measured with a microchemotaxis assay. A standard fluorimetric assay was used to assess changes in [Ca2]i in response
to the various combinations of growth factors and ECM proteins.
Results: The calcium ionophore A23187 produced a rapid rise in [Ca2]i and a corresponding 60% increase in SMC
migration, whereas chelation of [Ca2]i with BAPTA (1,2-bis [aminophenoxy] ethane-N,N,N,N-tetraacetic acid)
produced a fivefold decrease in PDGF-induced chemotaxis, suggesting that [Ca2]i is both sufficient and necessary for
SMC migration. Stimulation of SMCs with PDGF produced an early peak followed by a late plateau in [Ca2]i. To
establish a relationship between temporal fluctuations in [Ca2]i and SMC migration, SMCs were pretreated with
caffeine and ryanadine, which eliminated the initial peak but not the late plateau in [Ca2]i, and had no effect on
chemotaxis in response to PDGF. Incubation of SMCs with nickel chloride eliminated the late plateau, but had no effect
on the initial peak in [Ca2]i, and reduced PDGF-stimulated migration by fivefold. We then evaluated the role of calcium
in SMC migration induced by ECM proteins such as laminin, fibronectin, and collagen types I and IV. All four matrix
proteins stimulated SMC migration, but none produced an elevation in [Ca2]i. Moreover, preincubation of SMCs with
caffeine and ryanadine or nickel chloride had no effect on ECM protein-induced chemotaxis.
Conclusion: [Ca2]i transients are necessary for PDGF but not ECM protein-induced SMC chemotaxis. Moreover, the
ability of PDGF to stimulate vascular SMC migration appears dependent on influx of extracellular calcium through
membrane channels. (J Vasc Surg 2004;40:351-8.)
Clinical Relevance: Recurrent stenosis after angioplasty or surgical bypass remains a significant challenge in treating
vascular occlusive disease. In addition to growth factors, extracellular matrix (ECM) proteins may be potent agonists of
this process. In this study we show that the influx of extracellular calcium is an important mechanism for platelet-derived
growth factor–induced smooth muscle cell migration but not ECM-induced migration. Of note, in clinical trials calcium
channel blockers failed to inhibit recurrent stenosis. Our data provide mechanistic insight to help explain this negative
outcome in that therapies designed to inhibit restenosis depend on the effects of both growth factors and ECM proteins.Vascular smooth muscle cell (SMC) proliferation and
migration and the production of extracellular matrix
(ECM) contribute to the pathophysiology of intimal hyper-
plasia.1 Because few SMCs reside in the intimal layer of
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doi:10.1016/j.jvs.2004.03.047human vessels, SMC migration is an essential component of
the intimal process that leads to recurrent stenosis.2 A
variety of growth factors and ECM proteins act as agonists
of SMC migration.3,4 Platelet-derived growth factor
(PDGF) is one of the most potent SMC chemoattractants.5
However, ECM proteins also act as stimulants for SMC
migration, and their potency can be equivalent to or greater
than that of PDGF.6 Furthermore, ECM proteins may
interact in a synergistic manner with PDGF to enhance
SMC migration, which suggests overlapping yet distinct
mechanisms for induction of migration.7
Cell movement or migration is the result of a cyclic
process of cellular attachment and detachment.8 Cells bind
to ECM at specific sites termed focal adhesion complexes.9
Central to the focal adhesion is the integrin receptor, which
has a large extracellular domain, a membrane-spanning
domain, and a short cytoplasmic domain. The extracellular351
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grin. On the cytoplasmic side, integrins interact with the
actin cytoskeleton through a series of interconnecting pro-
teins. Actin filaments are visible as stress fibers that form a
framework or a structural skeleton that supports and shapes
the cell. Movement of a cell is an active process for which
there is a constant requirement for actin reorganization and
focal adhesion complex assembly and disassembly. The net
effect of this cyclic process is cellular locomotion.
There is substantial evidence in a number of cell types
that calcium has an essential role in migration. Fluctuations
in intracellular calcium ([Ca2]i) known as calcium tran-
sients are focally and temporally associated with migrating
eosinophils10 and neutrophils.11 Calcium transients have
also been observed in human vascular SMCs migrating in
response to serum12 and after mechanical injury.13 There
are multiple mechanisms through which calcium may facil-
itate migration. Voltage-gated calcium channels mediate
changes in [Ca2]i by enabling influx of extracellular ion
and G protein–coupled release of calcium from the sarco-
plasmic reticulum.14 Free [Ca2]i binds calmodulin, which
leads to activation of calmodulin-dependent protein kinase
(CAMK). Pauley et al15 have shown in vascular SMCs that
inhibition of CAMK-II results in a 90% reduction in
PDGF-stimulated migration. Thus CAMK-II may be the
central pathway through which calcium influences SMC
migration. Calcium also appears important for actin assem-
bly, and acts as a cofactor for proteins associated with focal
adhesions. Whether [Ca2]i is necessary for migration of
human SMCs in response to PDGF and ECM proteins is
not known. Moreover, the source of [Ca2]i and the
timing of its release after stimulation with agonists of
migration has not been explored.
MATERIAL AND METHODS
Reagents. Dulbecco modified Eagle medium
(DMEM), fetal bovine serum, phosphate-buffered saline
solution, N-2-hydroxyethylpiperazine-N-2-ethane sul-
fonic acid (HEPES), antibiotic-antimycotic, and trypsin–
ethylenediamine tetraacetic acid (EDTA) were obtained
from GIBCO BRL Life Technologies. Recombinant hu-
man PDGF-AB and PDGF-BB were obtained from Up-
state Biotechnologies. Anti-SMC actin, bovine fibronectin
(Fn), Engelberth-Holm Swarm mouse sarcoma laminin
(Lm), calfskin collagen I (CNI), human placental collagen
IV (CNIV), nickel chloride (NiCl2), and caffeine were
acquired from Sigma. Ionophore A23187 and ryanodine
were purchased from Calbiochem. Fura-2-acetoxymethyl
ester and 1,2-bis(o-aminophenoxyl)-ethyl,N,N,N,N-tet-
raacetic acid (BAPTA-AM) were obtained from Molecular
Probe. Polycarbonate 8-m pore membranes were pur-
chased from Poretics Corp.
Cell culture. Human SMCs were explanted from sa-
phenous veins harvested at peripheral arterial bypass graft-
ing, using an explant method as described in detail
previously.6,16
Measurement of [Ca2]i. Cellular calcium can be
evaluated in attached SMCs as well as SMCs in solution. Wechose the latter experimental model, because unattached
cells in solution are inert in that there has been no stimulus
for integrin activation. Alternatively, in attached cells inte-
grin activation may have already occurred, and may alter the
effects produced by the subsequent addition of growth
factors and matrix proteins.
Levels of [Ca2]i were measured with Fura-2 ace-
toxymethyl-ester (Fura-2), as described in detail else-
where.17 In brief, growth-arrested confluent SMCs were
washed twice with phosphate-buffered saline solution, then
gently harvested with 0.01% trypsin-EDTA. Detached cells
were resuspended in DMEM and centrifuged at 1000 rpm
for 5 minutes. The collected cells were then resuspended in
an assay buffer (20 mmol/L of HEPES [pH 7.4], 130
mmol/L of sodium chloride, 5 mmol/L of potassium
chloride, 1 mmol/L of magnesium dichloride, 1.5
mmol/L of calcium dichloride, 0.1% bovine serum albu-
min, and 10 mmol/L of glucose) containing 2 mol/L of
Fura-2, for 30 minutes at 37°C under 5% carbon dioxide.
Cells were again washed twice, and resuspended in an assay
buffer without Fura-2, for a final concentration of 1  106
cells per milliliter. Fluorescence was measured at 37°C with
a dual-excitation wavelength spectrofluorimeter apparatus
(SPEX; Fluorog-2).
Cells were placed in plastic cuvettes, and agonists were
added at the beginning of each measurement to attain the
final concentrations as indicated. Two excitations at 340 and
380 nm and one emission at 505 nm were recorded. The
experiments were individually calibrated with the addition
of 40 mol/L of digitonin and 20 mmol/L of ethylene-
glycol-bis-(-aminoethylether)-N,N,N,N-tetraacetic acid
(EGTA). The cytosoloic-free [Ca2]i was calculated by
using the ratio 340:380 nm of the emitted fluorescence
signal, as described by Grynkiewicz.17 Values were dis-
played graphically with SPEX DM3000 software.
Measurement of chemotaxis. Migration assays were
performed in a 48-well Boyden microchemotaxis chamber
(Neuro Probe), as described.6 Quiescent SMCs were har-
vested (0.01% trypsin-EDTA), and suspended (50,000
cells per well) into the upper wells of the chamber with and
without agonists or inhibitors. Solutions of PDGF-AB or
PDGF-BB, ECM proteins, or vehicle (0.01% bovine serum
albumin and 4 mmol/L hydrochloride) in 25 L of serum-
free DMEM were added to the wells of the lower chamber
of the Boyden apparatus, with upper and lower wells sepa-
rated by the polycarbonate filter membranes with 8.0-m
pores. PDGF isotypes (5 ng/mL) and ECM proteins (Lm
20 g/mL, Fn 20 g/mL, CNI 20 g/mL, CNIV 20
g/mL) were dissolved in aqueous solution and acetic
acid, respectively. For each experiment, appropriate vehicle
served as control. Migration was allowed to occur at 37°C
for 4 hours. The membrane was carefully removed, fixed
with ice-cold 70% ethanol, and stained overnight with
hematoxylin. The number of migrated cells on the lower
side was then counted in five independent random high-
power fields under 200 magnification with light micros-
copy. All experiments were repeated at least three times
with SMC preparations from different donors. The effects
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or decrease in migration  SE compared with appropriate
control sample.
Statistical analysis. Statistical comparisons were
made with an unpaired Student t test with Statview soft-
ware (SAS Institute) on a Macintosh G4 desktop computer
(Apple Computer). For comparisons, P  .05 was consid-
ered significant. Data displayed are representative.
RESULTS
Rise in [Ca2]i is sufficient for SMC migration. To
investigate whether elevation in [Ca2]i is sufficient for
SMC migration we examined the effect of the calcium
ionophore A23187 on [Ca2]i and SMC migration.
A23187 increases [Ca2]i by inducing release of [Ca
2]i
stores, which in turn activate store-operated calcium chan-
nels, enabling influx of extracellular calcium.18 SMCs were
stimulated with increasing concentrations of A23187
(1011-108 mol/L). A23187 concentrations of 108 and
109 mol/L produced an increase in [Ca2]i that peaked
at 25 to 45 seconds (Fig 1, A), and produced a significant
increase in SMC chemotaxis (53% and 60% over control;
P  .05; Fig 1, B). At concentrations of 1010 and 1011
mol/L, A23187 did not produce significant changes in
[Ca2]i or SMC chemotaxis. Cell toxicity from A23187
was noted at concentrations higher than 108 mol/L.
PDGF stimulates a rise in [Ca2]i. To further inves-
tigate the relationship between chemotaxis and [Ca2]i we
evaluated fluctuations in [Ca2]i in response to the potent
agonist of SMC migration, PDGF. Tracings that illustrate
the [Ca2]i response of SMCs stimulated with 5 ng/mL of
either PDGF-AB or PDGF-BB are shown in Fig 2, A. Both
isotypes produced a rise in [Ca2]i that was observed
within seconds of stimulation. Calcium levels peaked at
approximately 60 seconds for PDGF-BB and at 90 seconds
for PDGF-AB. We consistently found that PDGF-BB in-
duced an early peak in [Ca2]i that was substantially greater
than that for PDGF-AB. We observed a late plateau in
[Ca2]i that occurred 170 to 270 seconds after PDGF
stimulation that was roughly equivalent for both isotypes.
In parallel experiments the effect of PDGF-AB and
PDGF-BB on SMC migration was assessed (Fig 2, B). Both
isotypes of PDGF produced a significant increase in SMC
chemotaxis (PDGF-AB, 6.7; PDGF-BB, 8.8; P  .05).
Moreover, PDGF-BB consistently induced an approxi-
mately 30% greater increase in SMC chemotaxis than
PDGF-AB did. These results demonstrate that the two
PDGF isotypes tested induce a pattern of [Ca2]i release
and a chemotactic response that is isotype-specific.
Rise in [Ca2]i is necessary for PDGF-induced
chemotaxis. We next buffered [Ca2]i with the calcium
chelator BAPTA-AM. The AM derivative enables diffusion
of BAPTA into cells, whereas cleavage of the AM group
results in its cellular retention. Pretreatment for 30 minutes
with BAPTA-AM at 50 mol/L (Fig 3, A) did not alter
baseline calcium levels, but eliminated the early peak and
diminished the late plateau in [Ca2]i after PDGF stimula-
tion (5 ng/mL). Chemotaxis was then measured in SMCspreincubated for 30 minutes with 50 mol/L of
BAPTA-AM and then stimulated with PDGF-AB or
PDGF-BB. The presence of BAPTA-AM decreased PDGF-
AB–induced chemotaxis by 3.9-fold and PDGF-BB–
induced chemotaxis by 5.2-fold (P  .05 for each; Fig 3,
B). In parallel experiments with trypan blue exclusion,
exposure of SMCs to 50 mol/L of BAPTA-AM had no
effect on cell viability (data not shown).
Late plateau in [Ca2]i is the predominant signal
for PDGF-induced SMC migration. It has been estab-
lished in numerous cell types that the initial peak in agonist-
stimulated [Ca2]i is related to the release of intracellular
stores, whereas the late plateau is related to influx of extra-
cellular ion.19 To verify that this pattern is similar in human
saphenous vein SMCs, cells were cotreated with NiCl2,
which blocks the influx of extracellular calcium through
Fig 1. Effect of calcium ionophore A23187 on intracellular cal-
cium (A) and smooth muscle cell (SMC) migration (B). A, Qui-
escent SMCs were stimulated with A23187 (1011 to 108 mol/
L), and intracellular calcium was measured. Arrow indicates
introduction of A23187. B, With a microchemotaxis chamber,
quiescent SMCs were stimulated by adding A23187 (1011 to
108 mol/L) to the bottom chamber. Chemotaxis is expressed as
percent increase versus vehicle-treated control. Experiments were
performed in at least three cell lines from different donors, and data
shown are mean  SE of triplicate samples. *P  .05, A23187 vs
control.
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cium channels, or with caffeine plus ryanodine (Caff/Ryn),
which depletes sarcoplasmic reticular calcium stores. SMCs
were then stimulated with PDGF-AB or PDGF-BB (5
ng/mL), and [Ca2]i was measured. Pretreatment of
SMCs with NiCl2 (1 mol/L) had little or no effect on the
early peak of [Ca2]i after PDGF-AB and PDGF-BB stim-
ulation (Fig 4, A). However, NiCl2 eliminated the late
plateau for both PDGF isotypes. Pretreatment of SMCs
with Caff/Ryn (20 mmol/L per 20 mol/L for 20 min-
utes) resulted in loss of the early rise in [Ca2]i calcium
induced by both PDGF isotypes (Fig 4, C and D). How-
ever, within 60 seconds [Ca2]i began to rise, and steadily
increased to levels equivalent to that associated with the late
Fig 2. Effect of platelet-derived growth factor (PDGF)–AB and
PDGF-BB on intracellular calcium (A) and smooth muscle cell
(SMC) chemotaxis (B). A, Quiescent SMCs were stimulated with
PDGF-AB (5 ng/mL), PDGF-BB (5 ng/mL), and vehicle con-
trol, and intracellular calcium was measured. Arrow indicates in-
troduction of agonist. B, With a microchemotaxis chamber, qui-
escent SMCs were allowed to migrate toward PDGF-AB (5 ng/
mL) or PDGF-BB (5 ng/mL). Chemotaxis is expressed as fold
increase vs vehicle-treated control. Experiments were performed in
at least three cell lines from different donors, and data shown are
mean  SE of triplicate samples. *P  .05, PDGF vs control. **P
 .05, PDGF-AB vs PDGF-BB.plateau in control cells. Thus the early peak in [Ca2]i after
PDGF stimulation of SMCs is related to release of intracel-
lular calcium, and the late plateau is related to influx of
extracellular calcium.
We then explored whether the PDGF-induced migra-
tion depends on the early peak or the late plateau of
[Ca2]i. SMCs were seeded onto the membranes of a
microchemotaxis chamber and allowed to attach for 2
hours. Cells were then co-treated with NiCl2 (1 mol/L)
or pretreated with Caff/Ryn (20 mmol/L per 20 mol/L)
for 20 minutes before introduction of PDGF. In SMCs
treated with NiCl2 there was, respectively, a 4.6-fold and
5.5-fold reduction (P  .05) in PDGF-AB–induced and
Fig 3. Effect of 1,2-bis [aminophenoxy] ethane-N,N,N,N-tet-
raacetic acid (BAPTA) on platelet-derived growth factor (PDGF)–
BB–induced intracellular calcium (A) and chemotaxis (B). A,
Quiescent smooth muscle cells (SMCs) were stimulated with
PDGF-BB (5 ng/mL) with or without BAPTA (30 minutes pre-
treatment at 50 mol/L), and intracellular calcium was measured.
Arrow indicates introduction of PDGF. B, With a microchemo-
taxis chamber, quiescent SMCs were allowed to migrate toward
PDGF-BB (5 ng/mL) with or without BAPTA (30 minutes pre-
treatment at 50 mol/L). Chemotaxis is expressed as fold increase
vs vehicle-treated control. Experiments were performed in at least
three cell lines from different donors, and data shown are mean 
SE of triplicate samples. *P  .05, PDGF alone versus PDGF and
BAPTA.
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(PDGF)–AB–induced and PDGF-BB–induced intracellular calcium (A-D) and chemotaxis (E). Quiescent SMCs were
stimulated with PDGF-AB (5 ng/mL; A) and PDGF-BB (5 ng/mL; B), with or without NiCl2 (1 mol/L), and
intracellular calcium was measured. Arrow indicates introduction of PDGF. Quiescent SMCs were stimulated with
PDGF-AB (5 ng/ml; C) and PDGF-BB (5 ng/mL; D), with or without Caff/Ryn pretreatment (20 mmol/L per 20
mol/L for 20 minutes), and [Ca2]i was measured. Arrow indicates introduction of PDGF. E, With a microchemo-
taxis chamber, quiescent SMCs were allowed to migrate toward PDGF-AB (5 ng/mL) or PDGF-BB (5 ng/mL), with
or without NiCl2 (1 mol/L) or Caff/Ryn pretreatment (20 mmol/L per 20 mol/L for 20 minutes). Chemotaxis is
expressed as fold increase vs vehicle-treated control. Experiments were performed in at least three cell lines from
different donors, and data shown are mean  SE of triplicate samples. * P  .05, PDGF plus NiCl2 or PDGF plus
Caff/Ryn or PDGF plus Caff/Ryn and NiCl vs PDGF alone. ** P  .05, PDGF-AB vs PDGF-BB.2
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cells pretreated with Caff/Ryn demonstrated no change in
PDGF-AB–induced chemotaxis, and a 1.4-fold decrease in
Fig 5. A, Quiescent smooth muscle cells (SMCs) were stimulated
with the extracellular matrix (ECM) proteins laminin (Lm, 20 g/
mL), fibronectin (Fn, 20 g/mL), collagen type I (CNI, 20 g/
mL), or collagen type IV (CNIV, 20 g/mL), and intracellular
calcium was measured. Arrow indicates introduction of ECM pro-
teins. B, With a microchemotaxis chamber, quiescent SMCs were
allowed to migrate toward the same four soluble ECM proteins in the
presence or absence of NiCl2 (1 mol/L; B) or Caff/Ryn (20
mmol/L per 20mol/L for 20 minutes; C). Chemotaxis is expressed
as fold increase vs control. Experiments shown were performed in at
least three cell lines from different donors, and data shown are
mean  SE of triplicate samples. There were no significant differ-
ences between ECM protein, and ECM protein and Caff/Ryn.chemotaxis in response to PDGF-BB (P  .05). Pretreat-
ment of SMCs with both NiCl2 and Caff/Ryn produced,
respectively, a 5.1-fold and 6.4-fold reduction (P .05) in
chemotaxis for PDGF-AB and PDGF-BB. These reduc-
tions were similar to those observed with NiCl2 alone.
ECM-induced SMC chemotaxis is mediated by an
alternate, calcium-independent signaling pathway. We
have previously shown that ECM proteins such as Lm, Fn,
CNI, and CNIV induce chemotaxis of SMCs.6 We there-
fore postulated that [Ca2]i might have a similarly important
role in chemotaxis of SMCs in response to ECM. Thus we
evaluated whether ECM proteins could produce a rise in
[Ca2]i in human SMCs. SMCs were loaded with the fluores-
cent indicator Fura-2, then exposed to soluble ECM pro-
teins (Lm, 20 g/mL; Fn, 20 g/mL; CNI, 20 g/mL,
or CNIV, 20 g/mL). [Ca2]i transients were not observed
after stimulation with the various ECM proteins despite
observing calcium levels for up to 4 minutes (Fig 5, A).
To confirm that intracellular calcium transients are not
necessary for ECM-induced chemotaxis we stimulated
SMCs with ECM proteins in the presence of NiCl2 (1
mol/L) or after pretreatment with Caff/Ryn (20
mmol/L per 20 mol/L for 20 minutes). ECM proteins
induced a significant increase in SMC migration, as antici-
pated (Fig 5, B). However, treatment of SMCs with NiCl2
did not significantly alter SMC migration in response to Fn,
Lm, CNI, and CNIV (Fig 5, B). Thus, contrary to our
findings with PDGF, ECM-induced chemotaxis does not
require the influx of extracellular calcium. To evaluate
whether ECM protein–induced chemotaxis requires release
of intracellular calcium stores we performed similar studies
with Caff/Ryn. Pretreatment with Caff/Ryn also did not
alter the SMC response to Fn, Lm, CNI, or CNIV (Fig 5,
C). These results indicate that vascular SMC chemotaxis in
response to the ECM proteins Fn, Lm, CNI, and CNIV is
independent of calcium transients.
DISCUSSION
SMC migration is critical to development of intimal
hyperplasia. In previous studies we found soluble ECM
proteins to be potent stimuli of SMC migration; their
stimulus is equivalent to that of PDGF.6 Moreover, PDGF
and ECM proteins interact synergistically to promote SMC
chemotaxis.7 One method by which intimal thickening
might be controlled is through inhibition of the signaling
events necessary for SMC migration. Consequently we
explored the role of calcium in migration produced by both
growth factors and extracellular matrix.
Calcium ionophore produced a rapid rise in [Ca2]i
that mimicked the early peak observed when SMCs were
stimulated with growth factors such as PDGF. A late pla-
teau in [Ca2]i was also observed in response to ionophore,
but the intensity was substantially less than the plateau
observed with PDGF. The changes in [Ca2]i produced by
ionophore were sufficient to produce SMC chemotaxis,
albeit the response was small. Thus a rise in [Ca2]i,
independent of other stimuli, is sufficient to produce SMC
migration. Using BAPTA to sequester [Ca2] , we foundi
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to PDGF is calcium-dependent. The effect of eliminating
calcium fluctuations on PDGF-induced migration was pro-
found, with levels of chemotaxis returning near baseline.
These data suggest a critical role for calcium in the migra-
tion of vascular SMCs in response to PDGF.
It is well established in multiple cell types that PDGF
produces a rise in [Ca2]i. Binding of PDGF to its receptor
results in rapid production of inositol 1,4,5-triphosphate,
which stimulates release of calcium stores from the sarco-
plasmic reticulum.19 This early peak rise in [Ca2]i is
consistently followed by a prolonged plateau in [Ca2]i
related to influx of extracellular calcium through mem-
brane channels.20 Although we observed a similar temporal
pattern in human vascular SMCs stimulated with PDGF,
whether the early peak or the late plateau in [Ca2]i is
responsible for PDGF-induced cellular migration has not
been explored. To determine the relationship between
temporal elevations in [Ca2]i and SMC migration we used
inhibitors that selectively block the early peak and the late
plateau. Blocking the release of calcium from the sarcoplas-
mic reticulum and thus the initial rise in [Ca2]i did not
substantially influence migration. Alternatively, elimination
of the later plateau in [Ca2]i markedly inhibited SMC
chemotaxis for both isotypes of PDGF. Thus the chemo-
tactic response of PDGF appears to be largely related to
influx of extracellular calcium.
The timing of calcium release and its importance have
been explored in relation to SMC functions other than
migration. Using NiCl2 and Caff/Ryn, Kobayashi et al
21
found that neither early nor late calcium transients were
necessary for SMC mitosis or division. SMC contraction
appears to be related to both release of intracellular calcium
stores and influx of extracellular calcium, depending on the
stimulus. Influx of extracellular calcium is required for
arterial vasoconstriction resulting from increased intralumi-
nal pressure.22 In contrast, 	-adrenergic activation leading
to vascular SMC contraction is mediated primarily by re-
lease of intracellular calcium stores.23 These and other
studies demonstrate that the timing of calcium release and
the source of calcium are critically important in determin-
ing the effect of calcium on cellular function.
On the basis of our findings with PDGF, we postulated
that ECM protein–induced SMC chemotaxis would also
depend on calcium. However, we were not able to observe
a rise in [Ca2]i in human saphenous vein SMCs stimulated
with ECM proteins. Moreover, ECM-induced SMC che-
motaxis was unaffected by treatment with either Caff/Ryn
or NiCl2. In contrast to our findings, numerous investiga-
tors have shown that migration in response to ECM in most
cell types depends on a rise in [Ca2]i. There are some
exceptions. Leavesley et al24 demonstrated that endothelial
cell migration in response to collagen can occur in the
absence of [Ca2]i. Migration of endothelial cells on colla-
gen type I is mediated by the 	21 integrin, which suggests
that 	21 can stimulate migration independent of calci-
um.24 Conversely, vitronectin-mediated endothelial cell
migration, which is mediated by the 	V3 integrin, de-pends on [Ca2]i fluctuations.
24 These observations paral-
lel our findings with vascular SMCs. In previous studies
with saphenous vein SMCs we showed that blocking anti-
bodies to 	21 inhibit chemotaxis in response to these
same four matrix proteins, whereas antibodies to 	V3 do
not.25 Moreover, we now show that SMC migration in
response to CNI, CNIV, Fn, and Lm is calcium-indepen-
dent. Thus in human saphenous vein SMCs 	21 also
appears to facilitate migration in response to various matrix
proteins via a pathway that is independent of calcium. The
ability of 	21 to stimulate migration independent of
calcium seems universal. Hodgson and Dong26 observed in
human melanoma cells that a rise in [Ca2]i was neither
necessary nor sufficient for 	21-mediated cell migration
on collagen type IV. Of interest, human aortic SMCs seem
to behave differently. Bilato et al27 found that migration of
rat aortic SMCs on Fn is mediated by 	V3 and is calcium-
dependent.
It was predicted that calcium channel blockers would
prevent recurrent stenosis after coronary angioplasty. How-
ever, several large prospective trials have revealed little or
no advantage to these agents in prevention of recurrent
arterial occlusive disease.28,29 It is interesting that our data
predict success of calcium channel blockers as inhibitors of
SMC migration in response to PDGF but failure of these
agents to block the equally potent stimulus for migration
provided by ECM. Migration is admittedly only one com-
ponent of the hyperplastic process, and the complete expla-
nation for the failure of calcium channel blockers in treat-
ment of recurrent stenosis may be much more complex.
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